EGFR

44개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved44 programs
AntibodyLimited DatastaleWest China HospitalPhase 2

Vibecotecotamab combined with Putilimab for EGFR-positive refractory biliary malignant tumors (Vibecotecotamab combined with Putilimab for EGFR-positive refractory biliary malignant tumors)

Cancer of Biliary Duct · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#CancerofBiliaryDuct+1
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Cell Therapy Research …Phase 2

anti-CTLA-4/PD-1 expressing EGFR-CAR-T (anti-CTLA-4/PD-1 expressing EGFR-CAR-T)

Advanced Solid Tumor · EGFR

#EGFR#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleRenJi HospitalPhase 1

anti-EGFR CAR T (anti-EGFR CAR T)

Advanced Glioma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleAmgenPhase 2

EGFR inhibitors (panitumumab, panitumumab (EGFR inhibitors))

Recurrence Free Survival · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#RecurrenceFreeSurvival+1
Trials 1Status Recruiting

3 / 3 pages

← PreviousNext →